CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial in India
CYTOMED THERAPEUTICS LIMITED SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based...

IEEE Course Improves Technical Writing Skills
Crossroads Barrie Answers Canada’s Professional Driver Shortage with Versatile Driver Training Programs
IPB University and Simon Fraser University Discuss Research Collaboration, Double Degree, and Student Mobility